You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Medtronic
Harvard Business School
Colorcon
Mallinckrodt

Last Updated: April 7, 2020

DrugPatentWatch Database Preview

Cspc Ouyi Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CSPC OUYI, and what generic and branded alternatives to CSPC OUYI drugs are available?

CSPC OUYI has twenty-three approved drugs.



Summary for Cspc Ouyi
US Patents:0
Tradenames:17
Ingredients:17
NDAs:23

Drugs and US Patents for Cspc Ouyi

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cspc Ouyi CELECOXIB celecoxib CAPSULE;ORAL 210071-003 Jan 23, 2018 AB RX No No   Start Trial   Start Trial
Cspc Ouyi Pharm Co TRAMADOL HYDROCHLORIDE tramadol hydrochloride TABLET;ORAL 091498-001 Mar 29, 2013 AB RX No No   Start Trial   Start Trial
Cspc Ouyi METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 078321-002 Apr 17, 2008 AB RX No No   Start Trial   Start Trial
Cspc Ouyi MONTELUKAST SODIUM montelukast sodium TABLET, CHEWABLE;ORAL 209011-002 Apr 18, 2017 AB RX No No   Start Trial   Start Trial
Cspc Ouyi PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 211088-001 Oct 3, 2018 AB RX No No   Start Trial   Start Trial
Cspc Ouyi MEMANTINE HYDROCHLORIDE memantine hydrochloride TABLET;ORAL 209527-001 May 7, 2018 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Baxter
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.